Feds commit $ 3.2B to lock in Covid-19 wax supply ahead of fall vaccination campaign

Feds commit $ 3.2B to lock in Covid-19 wax supply ahead of fall vaccination campaign

The federal government has reached a deal to pay $ 3.2 billion to secure a new supply of the Pfizer / BioNTech Covid-19 vaccine that includes shots specifically adapted to the omicron variant that is now dominant. The agreement announced late Wednesday covers the purchase of 105 million doses. The government also has the option … Read more

Improving health equity through decentralized clinical trials

Improving health equity through decentralized clinical trials

A recent webinar by Medable discussed steps it’s taking to improve clinical trial design through decentralized clinical trials (DCT). The Covid-19 public health crisis has accelerated the adoption of DCT. But life science companies are taking steps to do more to increase diversity in clinical trial recruitment. Part of that effort involves figuring out how … Read more

Tomorrow Health raises $ 60M to get more payers on its home care coordination platform

Tomorrow Health raises $ 60M to get more payers on its home care coordination platform

The highly fragmented nature of the home care sector often results in delayed access and frustration for seniors hoping to age in place and patients seeking to manage their chronic conditions at home. When Tomorrow Health co-founder and CEO Vijay Kedar was coordinating his mother’s home care after she was hospitalized for a serious lung … Read more

Standard RPM programs end up creating more work for physicians, Cadence CEO says

Standard RPM programs end up creating more work for physicians, Cadence CEO says

“Technology is only as good as the impact it has on both patients and clinicians,” said Chris Altchek, founder and CEO of remote patient monitoring company Cadence. Cadence built its platform based on this idea. The startup, headquartered in New York, seeks to eliminate the burdened physicians face due to the huge volume of data … Read more

Bayer, Amgen join $ 120M financing for startup aiming to expand genetic meds delivery

Bayer, Amgen join $ 120M financing for startup aiming to expand genetic meds delivery

ReCode Therapeutics was formed around new science potentially enabling delivery of genetic medicines to various organs in the body, and the startup has encouraging data for its therapeutic candidates targeting the lungs. Now the biotech startup has $ 120 million to show that it can deliver on the technology’s promise in other organs and cell … Read more

Metaverse in healthcare – MedCity News

Metaverse in healthcare – MedCity News

Virtual and augmented reality have been a growing trend in healthcare, with hospitals applying the tech for surgery prep, reducing patient anxiety, and helping patients better understand how a procedure will be done. The virtual world will be part of the upcoming INVEST Digital Health conference, scheduled for Wednesday, September 28, in Dallas and presented … Read more

Amwell CEO on MedCity Pivot Podcast: Sometimes “we are punished” for biz models that have nothing to do with our approach

Amwell CEO on MedCity Pivot Podcast: Sometimes “we are punished” for biz models that have nothing to do with our approach

It’s the best of times. It’s the worst of times – for telehealth companies, that is. No one category has seen its value in healthcare delivery be proven during the pandemic so much so that the digital transformation of healthcare has catapulted from nice-to-have to must-have. Yet, no other category has seen a reversal of … Read more

Why obesity intervention needs to be a bigger part of chronic disease care

Why obesity intervention needs to be a bigger part of chronic disease care

Obesity has had an overwhelming presence in the US over the past few decades, but the problem has been exacerbated by the pandemic. The latest CDC data shows that 42% of Americans were obese in March 2020. A survey from the American Psychological Association, conducted last year, found that nearly half of Americans said they … Read more

Astellas pays Sutro Bio $ 90M to partner on cancer drugs that make cold tumors hot

Astellas pays Sutro Bio $ 90M to partner on cancer drugs that make cold tumors hot

Astellas Pharma already has a piece of the market for antibody drug conjugates (ADCs), a type of cancer therapy that has seen a surge in progress in recent years. The Japanese pharmaceutical giant co-developed Padcev, which has approvals in bladder cancer, under a partnership with US biotech Seagen. Astellas wants to take the targeted approach … Read more

Tips for tailoring eConsent for optimal patient centricity

Tips for tailoring eConsent for optimal patient centricity

Currently, according to Tufts researchers, clinical trials in a variety of therapeutic areas experience patient dropout rates close to 20%, with the consent process being the number one factor contributing to this figure. Additionally, according to Advarra, “35% of patients who dropped out of a study early reported that it was difficult to understand the … Read more